Oramed Pharmaceuticals (ORMP) Divestments (2011 - 2025)

Oramed Pharmaceuticals' (ORMP) quarterly Divestments came in at $2.8 million in Q3 2025, up 297.88% on a QoQ basis from $706000.0 in Q2 2025.

Oramed Pharmaceuticals (ORMP) Divestments (2011 - 2025) Analysis & Trends

Oramed Pharmaceuticals (ORMP) has 3 years of Divestments data on file, last reported at $2.8 million in Q3 2025.

Quarterly Divestments changed N/A year-over-year to $2.8 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 million (changed N/A YoY) and the FY2025 annual result came in at $6.3 million, changed N/A from the prior year.
Divestments improved to $2.8 million in Q3 2025, from $706000.0 in the prior quarter.
In the past five years, Divestments ranged from a high of $2.8 million in Q3 2025 to a low of $706000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-13.21 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	Oramed Pharmaceuticals	196.17 Mn	196.17 Mn	-	-

Download Data